Acutus Medical Inc
AFIB
AFIB was delisted on the 8th of May, 2024.
1 hedge funds and large institutions have $227 invested in Acutus Medical Inc in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 22 closing their positions.
96% less funds holding
Funds holding: 23 → 1 (-22)
100% less capital invested
Capital invested by funds: $1.24M → $227 (-$1.24M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 22
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$500K |
| 2 |
O
OrbiMed
New York
|
-$498K |
| 3 |
Renaissance Technologies
New York
|
-$65K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$52.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$38.9K |
AFIB Hedge Fund Activity: Q2 2024 in Review
1 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Acutus Medical Inc (AFIB) for Q2 2024, worth a combined $227 — down 100% from $1.24M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of AFIB and 0 opened new positions — a net loss of 22 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Deerfield Management, exiting entirely with an estimated $500K sold.
- 1 institutional investor held Acutus Medical Inc (AFIB) as of Q2 2024, down from 23 in Q1 2024.
- Funds reported $227 of Acutus Medical Inc stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Acutus Medical Inc positions in Q2 2024 and 22 closed out, a net change of -22 holders.
- The largest Acutus Medical Inc seller in Q2 2024 was Deerfield Management, an estimated $500K sold.
Based on aggregated 13F filings for Q2 2024.